Drug intelligence / Profile preview

Mag 2

Development stage
Unknown
Lead developer
Cooperation Pharmaceutique Francaise
Modality
Small Molecules
Administration
Oral
01

Overview

**Mag 2** is a French Cooper Consumer Health over-the-counter consumer-health brand covering multiple magnesium-containing products rather than one uniquely defined chemical entity. The range includes authorized oral medicines such as MAG 2 100 mg tablets containing magnesium carbonate and MAG 2 oral solution or sachet products containing magnesium pidolate, as well as dietary-supplement variants containing magnesium with ingredients such as vitamins, taurine, melatonin, or botanical extracts. The authorized MAG 2 100 mg tablet is used for symptoms that may suggest magnesium deficiency, including transient fatigue, mild anxiety or irritability, minor sleep disturbance, muscle cramps, and paresthesia.

Brand names
Mag 2Mag2Mag-2
Other names
MAG2MAG-2MAG 2
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on Mag 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mag 2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call